Cargando…

Synthesis and Evaluation of Technetium-99m-Labeled pH (Low) Insertion Peptide Variant 7 for Early Diagnosis of MDA-MB-231 Triple-Negative Breast Cancer by Targeting the Tumor Microenvironment

OBJECTIVE: To prepare technetium-99m ((99m)Tc)-labeled pH (low) insertion peptide variant 7 [pHLIP (Var7)] and carry out small-animal single-photon-emission computed tomography (SPECT)/computed tomography (CT) imaging of tumor-bearing nude mice in vivo to study its value in the early diagnosis of tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yuehua, Su, Yuan, Pang, Xufeng, Song, Xiaoxia, Zhao, Wanjun, Yu, Mingming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069674/
https://www.ncbi.nlm.nih.gov/pubmed/35530359
http://dx.doi.org/10.3389/fonc.2022.869260
_version_ 1784700480774995968
author Chen, Yuehua
Su, Yuan
Pang, Xufeng
Song, Xiaoxia
Zhao, Wanjun
Yu, Mingming
author_facet Chen, Yuehua
Su, Yuan
Pang, Xufeng
Song, Xiaoxia
Zhao, Wanjun
Yu, Mingming
author_sort Chen, Yuehua
collection PubMed
description OBJECTIVE: To prepare technetium-99m ((99m)Tc)-labeled pH (low) insertion peptide variant 7 [pHLIP (Var7)] and carry out small-animal single-photon-emission computed tomography (SPECT)/computed tomography (CT) imaging of tumor-bearing nude mice in vivo to study its value in the early diagnosis of triple-negative breast cancer (TNBC). METHODS: The pHLIP (Var7) sequence was synthesized via solid-phase peptide synthesis. Four amino acids, Gly-(D)-Ala-Gly-Gly, were attached to the N-terminus of pHLIP (Var7) to form a strong chelating group containing an N4 structure. The peptide was labeled with (99m)Tc using a direct labeling method. We determined the in vitro binding fraction of (99m)Tc-pHLIP (Var7) to MDA-MB-231 cells. Serial biodistribution studies and small-animal SPECT/CT imaging in MDA-MB-231 TNBC-bearing mice were performed using (99m)Tc-pHLIP (Var7). RESULTS: The radiochemical yield and purity of (99m)Tc-pHLIP (Var7) were 99.49 ± 0.17% and 99.63 ± 0.44%, respectively. The radiochemical purity was still more than 96% after 24 h in serum. The binding fraction of (99m)Tc-pHLIP (Var7) to MDA-MB-231 cells continuously increased in an acidic environment and was significantly higher than the cell-binding fraction (P < 0.01) at pH = 7.4 and the cell-binding fraction (P < 0.01) of (99m)Tc-kVar7 at different pH values (pH = 6.0, 6.5, 7.0 and 7.4) at each time point (P < 0.01). The distribution of (99m)Tc-pHLIP (Var7) in tumors at each time point was significantly greater than that of (99m)Tc-kVar7 (P < 0.01). SPECT/CT imaging was largely consistent with the biodistribution results; the tumor was clearly imaged at each time point after injection of (99m)Tc-pHLIP (Var7) but could not be imaged after injection of (99m)Tc-kVar7. CONCLUSION: (99m)Tc-pHLIP (Var7) showed a high radiochemical yield and stability and was highly concentrated in tumor tissues. Although there was strong radioactive background in the abdomen of tumor-bearing nude mice, it did not hinder early diagnosis of TNBC.
format Online
Article
Text
id pubmed-9069674
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90696742022-05-05 Synthesis and Evaluation of Technetium-99m-Labeled pH (Low) Insertion Peptide Variant 7 for Early Diagnosis of MDA-MB-231 Triple-Negative Breast Cancer by Targeting the Tumor Microenvironment Chen, Yuehua Su, Yuan Pang, Xufeng Song, Xiaoxia Zhao, Wanjun Yu, Mingming Front Oncol Oncology OBJECTIVE: To prepare technetium-99m ((99m)Tc)-labeled pH (low) insertion peptide variant 7 [pHLIP (Var7)] and carry out small-animal single-photon-emission computed tomography (SPECT)/computed tomography (CT) imaging of tumor-bearing nude mice in vivo to study its value in the early diagnosis of triple-negative breast cancer (TNBC). METHODS: The pHLIP (Var7) sequence was synthesized via solid-phase peptide synthesis. Four amino acids, Gly-(D)-Ala-Gly-Gly, were attached to the N-terminus of pHLIP (Var7) to form a strong chelating group containing an N4 structure. The peptide was labeled with (99m)Tc using a direct labeling method. We determined the in vitro binding fraction of (99m)Tc-pHLIP (Var7) to MDA-MB-231 cells. Serial biodistribution studies and small-animal SPECT/CT imaging in MDA-MB-231 TNBC-bearing mice were performed using (99m)Tc-pHLIP (Var7). RESULTS: The radiochemical yield and purity of (99m)Tc-pHLIP (Var7) were 99.49 ± 0.17% and 99.63 ± 0.44%, respectively. The radiochemical purity was still more than 96% after 24 h in serum. The binding fraction of (99m)Tc-pHLIP (Var7) to MDA-MB-231 cells continuously increased in an acidic environment and was significantly higher than the cell-binding fraction (P < 0.01) at pH = 7.4 and the cell-binding fraction (P < 0.01) of (99m)Tc-kVar7 at different pH values (pH = 6.0, 6.5, 7.0 and 7.4) at each time point (P < 0.01). The distribution of (99m)Tc-pHLIP (Var7) in tumors at each time point was significantly greater than that of (99m)Tc-kVar7 (P < 0.01). SPECT/CT imaging was largely consistent with the biodistribution results; the tumor was clearly imaged at each time point after injection of (99m)Tc-pHLIP (Var7) but could not be imaged after injection of (99m)Tc-kVar7. CONCLUSION: (99m)Tc-pHLIP (Var7) showed a high radiochemical yield and stability and was highly concentrated in tumor tissues. Although there was strong radioactive background in the abdomen of tumor-bearing nude mice, it did not hinder early diagnosis of TNBC. Frontiers Media S.A. 2022-04-21 /pmc/articles/PMC9069674/ /pubmed/35530359 http://dx.doi.org/10.3389/fonc.2022.869260 Text en Copyright © 2022 Chen, Su, Pang, Song, Zhao and Yu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Chen, Yuehua
Su, Yuan
Pang, Xufeng
Song, Xiaoxia
Zhao, Wanjun
Yu, Mingming
Synthesis and Evaluation of Technetium-99m-Labeled pH (Low) Insertion Peptide Variant 7 for Early Diagnosis of MDA-MB-231 Triple-Negative Breast Cancer by Targeting the Tumor Microenvironment
title Synthesis and Evaluation of Technetium-99m-Labeled pH (Low) Insertion Peptide Variant 7 for Early Diagnosis of MDA-MB-231 Triple-Negative Breast Cancer by Targeting the Tumor Microenvironment
title_full Synthesis and Evaluation of Technetium-99m-Labeled pH (Low) Insertion Peptide Variant 7 for Early Diagnosis of MDA-MB-231 Triple-Negative Breast Cancer by Targeting the Tumor Microenvironment
title_fullStr Synthesis and Evaluation of Technetium-99m-Labeled pH (Low) Insertion Peptide Variant 7 for Early Diagnosis of MDA-MB-231 Triple-Negative Breast Cancer by Targeting the Tumor Microenvironment
title_full_unstemmed Synthesis and Evaluation of Technetium-99m-Labeled pH (Low) Insertion Peptide Variant 7 for Early Diagnosis of MDA-MB-231 Triple-Negative Breast Cancer by Targeting the Tumor Microenvironment
title_short Synthesis and Evaluation of Technetium-99m-Labeled pH (Low) Insertion Peptide Variant 7 for Early Diagnosis of MDA-MB-231 Triple-Negative Breast Cancer by Targeting the Tumor Microenvironment
title_sort synthesis and evaluation of technetium-99m-labeled ph (low) insertion peptide variant 7 for early diagnosis of mda-mb-231 triple-negative breast cancer by targeting the tumor microenvironment
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069674/
https://www.ncbi.nlm.nih.gov/pubmed/35530359
http://dx.doi.org/10.3389/fonc.2022.869260
work_keys_str_mv AT chenyuehua synthesisandevaluationoftechnetium99mlabeledphlowinsertionpeptidevariant7forearlydiagnosisofmdamb231triplenegativebreastcancerbytargetingthetumormicroenvironment
AT suyuan synthesisandevaluationoftechnetium99mlabeledphlowinsertionpeptidevariant7forearlydiagnosisofmdamb231triplenegativebreastcancerbytargetingthetumormicroenvironment
AT pangxufeng synthesisandevaluationoftechnetium99mlabeledphlowinsertionpeptidevariant7forearlydiagnosisofmdamb231triplenegativebreastcancerbytargetingthetumormicroenvironment
AT songxiaoxia synthesisandevaluationoftechnetium99mlabeledphlowinsertionpeptidevariant7forearlydiagnosisofmdamb231triplenegativebreastcancerbytargetingthetumormicroenvironment
AT zhaowanjun synthesisandevaluationoftechnetium99mlabeledphlowinsertionpeptidevariant7forearlydiagnosisofmdamb231triplenegativebreastcancerbytargetingthetumormicroenvironment
AT yumingming synthesisandevaluationoftechnetium99mlabeledphlowinsertionpeptidevariant7forearlydiagnosisofmdamb231triplenegativebreastcancerbytargetingthetumormicroenvironment